Histopathological Study on Conservatively Operated Breast Carcinomas.

Publisher: Medical University Publishing House Country of Publication: Romania NLM ID: 101597164 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2067-0656 (Print) NLM ISO Abbreviation: Curr Health Sci J Subsets: PubMed not MEDLINE

Publication: <2013>- : Craiova : Medical University Publishing House
Original Publication: Craiova : Editura Medicală Universitară

In this histopathological study we looked at 303 cases of breast carcinomas, managed though conservative breast surgery and later analysed with the help of a classical histopathological technique, paraffin embedding. The carcinomas were assessed in terms of tumor size, lymph node status, histological type, correlation between invasive tumors and an situ carcinoma component, resection margins, grading and patients age. Following assessment, we looked at associations between above morphological and clinical parameters and ipsilateral local recurrences. We concluded that more than half of our cases were carcinomas, measuring between 2 cm and 5 cm, with no associated lymph node involvement, in keeping with pTNM criteria for stage II. By far, in our study, the most frequent histopathological type was type NOS (63.37%) followed by invasive lobular carcinoma (10.56%) and mixed ducto-lobular invasive carcinoma (6.27%). Other types of invasive carcinoma were rarer, each representing less than 4% of cases. In regards to in situ carcinomas we noted the most common histological types to be both cribriform intraductal carcinoma and comedocarcinoma, each identified in 1.65% of cases. Amongst invasive breast carcinomas, infiltrating ductal carcinoma not otherwise specified (NOS) was found to be most commonly associated with in situ ductal carcinoma lesions. This was seen in 34.9% of cases, and was the only type associated with an extensive in situ component. Analysing the grading of mammary carcinomas in our study showed that the vast majority of cases (63.04%) were grade 3 tumors. In regards to surgical resection margins, ¾ of cases were noted to have negative margins. Tumor recurrences were noted in 12 cases. These cases were most commonly noted to reoccur following initial poorly differentiated, infiltrating ductal carcinomas, not otherwise specified (NOS), with positive resection margins, measuring less than 2 cm. Patiens tended to be under the age of 40 and had positive lymph nodes. The emergence of local recurrences after conservative surgery for early breast cancer is singnificantly linked to poorly differentiated primary tumors (p <0.05) but not correlated with histological type, presence of extensive intraductal carcinoma component, size of primary breast tumor or lymph node status ( p> 0.05). In terms of increasing the risk of ipsilateral recurrence the most important aspect highlighted in our sudy was the status of the resection margins. Patients with positive resection margins had a significantly high risk to develop recurrences after the conservative surgery, compared to those with negative margins (p <0.001).

Eur J Cancer. 1999 Dec;35(13):1828-37. (PMID: 10673999)
J Natl Cancer Inst. 2000 Jul 19;92(14):1143-50. (PMID: 10904087)
Eur J Cancer. 2001 Oct;37(15):1820-7. (PMID: 11576834)
Lancet. 2000 May 20;355(9217):1757-70. (PMID: 10832826)
Mod Pathol. 2007 Feb;20(2):183-91. (PMID: 17206106)
J Natl Cancer Inst. 1975 Aug;55(2):231-73. (PMID: 169369)
J Natl Cancer Inst. 2000 Apr 5;92(7):550-6. (PMID: 10749910)
Lancet. 2005 Dec 17;366(9503):2087-106. (PMID: 16360786)
J Natl Cancer Inst. 1995 Jan 4;87(1):19-27. (PMID: 7666458)
Breast Cancer (Auckl). 2011;5:105-15. (PMID: 21695097)
J Natl Cancer Inst. 2004 Jan 21;96(2):115-21. (PMID: 14734701)
Ann R Coll Surg Engl. 2010 Oct;92(7):562-8. (PMID: 20522309)
Cancer. 1989 May 15;63(10):1912-7. (PMID: 2702564)
Breast J. 2002 Sep-Oct;8(5):263-8. (PMID: 12199752)
Cancer. 1994 Sep 15;74(6):1746-51. (PMID: 8082077)
Eur J Surg Oncol. 1991 Aug;17(4):338-41. (PMID: 1874290)
Cancer. 2006 Jan 1;106(1):35-41. (PMID: 16333848)
J Clin Oncol. 2009 Feb 20;27(6):927-32. (PMID: 19114687)
Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):833-42. (PMID: 2170305)
Cancer. 2002 Nov 15;95(10):2059-67. (PMID: 12412158)
Breast J. 1999 Mar;5(2):105-111. (PMID: 11348268)
J Clin Oncol. 2005 Mar 10;23(8):1685-97. (PMID: 15755977)
Radiother Oncol. 1990 Sep;19(1):29-41. (PMID: 2173044)
J Egypt Natl Canc Inst. 2006 Sep;18(3):183-90. (PMID: 17671527)
Ann Oncol. 2011 Apr;22(4):842-847. (PMID: 21048040)
Br J Cancer. 1990 Jun;61(6):873-6. (PMID: 2164836)
Semin Surg Oncol. 1992 May-Jun;8(3):161-6. (PMID: 1496227)
Radiology. 1992 Apr;183(1):273-6. (PMID: 1549685)
N Engl J Med. 2002 Oct 17;347(16):1233-41. (PMID: 12393820)
J Clin Oncol. 2002 Oct 1;20(19):4015-21. (PMID: 12351599)
Cancer. 2003 Mar 1;97(5):1156-63. (PMID: 12599220)
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38. (PMID: 9989511)
JAMA. 1991 Jan 16;265(3):391-5. (PMID: 1984541)
J Natl Cancer Inst. 1973 May;50(5):1111-8. (PMID: 4123242)
Cancer. 1995 May 1;75(9):2328-36. (PMID: 7712444)
Ann Surg. 1993 Jul;218(1):22-8. (PMID: 8328825)
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1281-9. (PMID: 11121624)
Cancer J Sci Am. 1998 Sep-Oct;4(5):302-7. (PMID: 9815294)
Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15. (PMID: 10421533)
Arch Surg. 1991 Apr;126(4):490-3. (PMID: 2009065)
N Engl J Med. 2002 Oct 17;347(16):1227-32. (PMID: 12393819)
Am J Clin Pathol. 2007 Jul;128(1):86-91. (PMID: 17580274)
Crit Rev Oncol Hematol. 2003 Mar;45(3):313-25. (PMID: 12633842)
Ann Oncol. 2006 Mar;17(3):401-8. (PMID: 16330517)
Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):293-8. (PMID: 2061106)
N Engl J Med. 1999 May 13;340(19):1455-61. (PMID: 10320383)

Keywords: breast cancer; breast conserving surgery; histopathological; recurrence

Date Created: 20181225 Latest Revision: 20231004

20240105

PMC6269607

10.12865/CHSJ.42.03.07

30581581